“Updates on Dual Anti-platelet Therapy in Acute Ischemic Stroke Patients”
HealthTrust presents…”Updates on Dual Anti-platelet Therapy in Acute Ischemic Stroke Patients”
Most patients currently suffering from acute ischemic stroke are discharged from the hospital on single anti-platelet therapy with aspirin. However, recent literature has identified benefits with the use of dual antiplatelet therapy (DAPT) for this patient population. Studies in acute coronary syndrome have demonstrated the benefit with DAPT in secondary prevention of future ischemic events. The speaker will provide strategies for pharmacists to identify patients who would benefit from such therapy
Learning Objectives for Pharmacists | At the end of this session, participants should be able to:
- Define the role of anti-platelet therapy in patients with acute ischemic attack
- Recall the current literature for the use of dual anti-platelet therapy (DAPT) in acute ischemic stroke
- Differentiate amongst patients who would benefit most from DAPT
- Outline a treatment regimen using DAPT in a patient specific case
Learning Objectives for Pharmacy Technicians | At the end of this session, participants should be able to:
- Identify anti-platelet agents used in secondary prevention of ischemic stroke
- Specify one patient type that would benefit from antiplatelet agents after an initial stroke
Parth Parikh, PharmD | PGY-2 Emergency Medicine Pharmacy Resident | Robert Wood Johnson University Hospital
Target Audience: Pharmacists & Pharmacy Techs
Continuing Education Information: 1.0 contact hours is approved for Pharmacists and Pharmacy Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-039-L01-P and 0863-9999-19-039-L01-T. The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists and pharmacy technicians who attend the webinar and complete the online evaluation.
Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at firstname.lastname@example.org. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.